AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012
May 31, 2012
30583_dirs_2012-05-31_5f3e7adf-f456-4309-997d-c599e2ce0a03.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-05-31
Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-31 | Common Stock | M | 8000 | $6.46 | Acquired | 176691 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-31 | Stock Option (right to buy) | $6.46 | M | 8000 | Disposed | 2015-11-10 | Common Stock (8000) | Direct |
Footnotes
F1: Original option grant vested 1/3 each on May 11, 2006, May 11, 2007, and May 11, 2008.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19